Trending Clinical Topics for January 2018

Ryan Syrek


January 26, 2018

Clinical Trend of the Week (January 6-12): Scleroderma

The findings from a clinical trial that examined a new therapeutic regimen for a life-threatening autoimmune disease resulted in this week’s top search term. The study investigated the effect of myeloablative autologous hematopoietic stem cell transplant (HSCT) on patients with severe scleroderma. The results showed that the regimen, which includes chemotherapy and total body radiation, improved survival and quality of life for people with the condition. In fact, the study found that HSCT was superior to treatment with cyclophosphamide, an immune-suppressing drug. Because diffuse systemic sclerosis is often fatal, new potential treatment options are sure to capture the interest of healthcare professionals treating those with the condition.

For more information on scleroderma, read here


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.